SCON Superconductor Technologies Inc

On December 7, 2021, James T. Walesa, the Chairman and Chief Executive Officer of Clearday, Inc. (the “Company”), entered into a pre-arranged stock trading plan (the “Trading Plan”) to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Company’s insider trading policy. Rule 10b5-1 permits a public company’s directors and executive officers to adopt written, pre-arranged plans for trading in the company’s securities under specified conditions and for specified periods of time when such insiders are not in possession of material, non-public information about the company.

The Trading Plan entered into by Mr. Walesa authorizes a broker-dealer to purchase on Mr. Walesa’s behalf up to $50,000 of the Company’s Common Stock (the “Purchase Amount”) on the open market or otherwise at prevailing market prices, subject to the maximum price threshold specified in the Trading Plan, until January 31, 2022 or after a total number of shares of the Common Stock equal to the Purchase Amount have been purchased. In accordance with Rule 10b5-1 and the terms of the Trading Plan, Mr. Walesa has no discretion or control over the timing or effectuation of purchases of the Common Stock that are made pursuant to the Trading Plan.

Mr. Walesa currently beneficially owns 1,004,863 shares of the Common Stock, including convertible securities that may be exchanged for shares of the Common Stock. Mr. Walesa’s combined ownership of 2,009,654 securities which represents approximately 13.5% of the total shares of the Company’s Common Stock as of September 30, 2021.

The transactions executed in accordance with the Trading Plan will be reported to the Securities and Exchange Commission through Form 4 filings pursuant to Section 16 of the Exchange Act and in accordance with applicable securities laws, rules, and regulations. Except as required by law, the Company does not undertake to report on specific Rule 10b5-1 trading plans that may be adopted by officers, directors, or other insiders of the Company in the future or to report any modifications or termination of any publicly announced trading plan.